|
Brain Cancer Research Studies
RECURRENT
N0272 Phase II
Trial of Imatinib Mesylate; (Gleevec; STI-571) in Treatment of Recurrent
Oligodendroglioma and Mixed Oligoastrocytoma
N0572 A Phase
I/II Trial of Sorafenib and CCI-779 in Patients with Recurrent Glioblastoma
METASTATIC
N0574 Phase III
Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to
Radiosurgery in Patients with One to Three Cerebral Metastases
|